Dinesh V Patel, Director, President and Chief Executive Officer, on August 10, 2026, sold 100,000 shares in Protagonist Therapeutics (PTGX) for $14,890,799. Following the Form 4 filing with the SEC, Patel has control over a total of 523,478 common shares of the company, with 523,478 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1377121/000110465926095111/xslF345X05/tm2622954-1_4seq1.xml